Squarepoint
CNST

Squarepoint’s Constellation Pharmaceuticals, Inc. CNST Stock Holding History

Squarepoint’s Portfolio CNST Stock Details CNST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-15,064
Closed -$305K – 3410
2020
Q3 		$305K Sell
15,064
-3,696
-20% -$90.2K ﹤0.01% 1789
2020
Q2 		$564K Buy
18,760
+4,222
+29% +$152K 0.01% 1256
2020
Q1 		$457K Sell
14,538
-2,605
-15% -$90.6K 0.01% 1093
2019
Q4 		$808K Buy
+17,143
New +$495K ﹤0.01% 1467
2019
Q3 		– Sell
-11,400
Closed -$140K – 2804
2019
Q2 		$140K Buy
+11,400
New +$127K ﹤0.01% 2172

Other funds holding CNST

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
CG
Column Group San Francisco, California $101M AUM 290.34% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PM
Ponoi Management San Francisco, California $73.2M AUM 23.44% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

Squarepoint's CNST Position: Q4 2020 in Review

Squarepoint sold out of Constellation Pharmaceuticals, Inc. (CNST) in Q4 2020, closing a stake of 15,064 shares — an estimated $305K sold.

Squarepoint first reported a position in CNST in Q2 2019 and held it in 5 quarters. The position peaked at $808K in Q4 2019. 134 funds tracked by Wall St. Rank hold CNST as of Q4 2020.

  • Squarepoint reported no remaining Constellation Pharmaceuticals, Inc. position as of Q4 2020 after selling out during the quarter.
  • Squarepoint sold 15,064 Constellation Pharmaceuticals, Inc. shares in Q4 2020, an estimated $305K.
  • Squarepoint first reported a position in Constellation Pharmaceuticals, Inc. in Q2 2019 and held it in 5 quarters.
  • Squarepoint's Constellation Pharmaceuticals, Inc. position peaked at $808K in Q4 2019.
  • 134 funds tracked by Wall St. Rank held Constellation Pharmaceuticals, Inc. as of Q4 2020.

Based on Squarepoint's 13F filing for Q4 2020, filed 16 Feb 2021.